tm logo

Monitor this mark

View On USPTO

AESLEPIX
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 05 Jul 2021

Last Applicant/ Owned by

AsclepiX Therapeutics, Inc.

185 Hudson Street, Suite 2500

Jersey City

NJ

07311

Serial Number

88944663 filed on 02th Jun 2020

Registration Number

N/A

Correspondent Address

Rachelle A. Dubow, Esq.

RACHELLE A. DUBOW, ESQ.

ONE FEDERAL STREET

BOSTON, MA 02110

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

AESLEPIX

Therapeutic pharmaceutical for the treatment of retinal diseases and cancer; ocular pharmaceuticals; pharmaceuticals products for the treatment of cancer Pharmaceutical research and development

Classification Information

Class [005]
Pharmaceutical Products

Therapeutic pharmaceutical for the treatment of retinal diseases and cancer; ocular pharmaceuticals; pharmaceuticals products for the treatment of cancer

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical research and development

Mark Details

Serial Number

No 88944663

Mark Type

No Service Mark

Attorney Docket Number

No 114293-0004

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Status DateAction Taken
06th Jul 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
05th Jul 2021ABANDONMENT - NO USE STATEMENT FILED
01st Dec 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06th Oct 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06th Oct 2020PUBLISHED FOR OPPOSITION
16th Sep 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02th Sep 2020APPROVED FOR PUB - PRINCIPAL REGISTER
02th Sep 2020ASSIGNED TO EXAMINER
24th Jun 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
05th Jun 2020NEW APPLICATION ENTERED IN TRAM